Developer docs
API playgroundTry for free, no card

Search company profiles

AlgaeCytes

Full company profile

uuid0002vyo

Namestring
AlgaeCytes
Legal namestring
AlgaeCytes Limited
Websiteurl
algaecytes.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

AlgaeCytes is a UK-based biotechnology company founded in 2010 that cultivates freshwater microalgae in enclosed photobioreactor systems to produce sustainable, vegan-friendly ingredients for B2B customers. The company operates from its headquarters at Discovery Park in Sandwich, Kent, with a wholly owned German subsidiary (AlgaeCytes Germany GmbH) running a 100,000 square meter commercial-scale plant in Dessau-Roßlau, Saxony-Anhalt, that commenced operations in 2024. AlgaeCytes' core technology consists of rows of enclosed glass tubing with LED-stimulated photosynthesis, controlled temperature, and regulated nutrient supply, enabling year-round 24/7 production independent of weather and protection against heavy metals, PCBs, and pesticides. Its product portfolio centers on the proprietary ALG01 microalgae strain and includes AVEPADaily (Omega-3 EPA algal oil for nutraceuticals and dietary supplements), ALG01 Grow (an agricultural biostimulant for organic crop cultivation), and ALG01 Origin (versatile algal biomass for personal care, functional food, and pharmaceutical applications).

The company sells ingredients under a one-time/license B2B model to nutraceutical, sports nutrition, personal care and cosmetics, pharmaceutical, and agricultural customers globally, going to market primarily through enterprise field sales and industry event participation (SupplySide West 2023/2024, GOED Exchange 2024). Pricing is not publicly disclosed, and no anchor customer logos or revenue figures are reported. Since 2013, Deepbridge Capital LLP has been the principal financial backer via the Deepbridge Technology Growth EIS fund, with additional support from Kent County Council and approximately $12.5M from the German Federal Ministry for Economic Affairs and Energy (BMWi) in 2022 toward the Dessau build. AlgaeCytes is transitioning from pilot-scale operations (Kent, since November 2017) to commercial-scale production (Dessau, since 2024) and maintains R&D partnerships with KAUST, Fraunhofer Institute, University of Manchester, University of Nottingham, and Anhalt University of Applied Sciences.

Short descriptiontext

AlgaeCytes is a UK biotechnology company that uses enclosed photobioreactors and proprietary freshwater microalgae strains to produce vegan Omega-3 EPA oils, agricultural biostimulants, and algal biomass ingredients for B2B customers in nutraceuticals, sports nutrition, personal care, pharmaceutical, and agricultural markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSandwich, United Kingdom
HQ citystring
Sandwich
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microalgae cultivation, omega-3 EPA oil, algal biostimulants, photobioreactor systems, algae-derived ingredients
Industry3 codes
PRIMARYAFAEAAAE
Seaweed & Algae Aquaculture (incl. microalgae)
Agriculture & Food Production/Animal Production & Aquaculture/Aquaculture (Fish & Shellfish Farming)
SECONDARYAFABAEAK
Biostimulants & Plant Health Biologicals (Microbial/Non-microbial)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYAFAJAHAF
Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
NAICS code3 codes
  • Aquaculture1125
  • Other Aquaculture112519
  • Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing3253
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Biological Products, (No Disgnostic Substances)2836
Product category
Microalgae-derived ingredients
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Omega-3 EPA Algal Oil Sales
TypeOne Time License
Description

AlgaeCytes produces and sells AVEPADaily, a premium Omega-3 EPA algal oil to B2B customers in dietary supplements, sports nutrition, personal care & cosmetics, and pharmaceutical markets. The product is positioned as a natural, vegan-friendly, non-GMO alternative to fish oil.

algaecytes.com
2Agricultural Biostimulant Sales
TypeOne Time License
Description

ALG01 Grow, a sustainable algal-based agricultural crop biostimulant sold to the agricultural sector for organic crop cultivation, promoting healthier plant growth and soil health.

algaecytes.com
3Algal Biomass Ingredients
TypeOne Time License
Description

Sale of ALG01 Origin versatile algal biomass to various industries including nutraceuticals, personal care, functional food, and pharmaceuticals.

algaecytes.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Infrastructure, Personnel, Operations, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1AVEPADaily
Description

Premium range of Omega-3 EPA algal oil - a natural, vegan-friendly, and non-GMO source of Omega-3 EPAs for nutraceuticals and wellness products.

algaecytes.com
+2 more records
Core offering1 text field

AlgaeCytes cultivates microalgae in enclosed photobioreactor systems to produce and sell B2B ingredients including AVEPADaily Omega-3 EPA algal oil, ALG01 Grow agricultural biostimulant, and ALG01 Origin versatile algal biomass. The company supplies these all-natural, vegan-friendly, non-GMO ingredients to dietary supplement, sports nutrition, personal care & cosmetics, pharmaceutical, and agricultural customers globally. Production occurs in fully enclosed facilities using proprietary freshwater microalgae strains and patented processes that enable year-round, contaminant-free manufacturing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Contaminant-free: No heavy metals, PCBs, pesticides, or environmental pollutants in products
+3 more records
Product overview1 text field

AlgaeCytes is a biotechnology company that cultivates microalgae to produce high-value natural ingredients for B2B customers. The company offers two core product lines: (1) AVEPADaily, a premium Omega-3 EPA algal oil derived from the proprietary ALG01 strain - the first vegan and non-GMO alternative to traditional fish oils; and (2) ALG01 Grow, an agricultural biostimulant made from nutrient-rich algal biomass for organic crop cultivation. The company also produces ALG01 Origin, a versatile algal biomass ingredient. All products are cultivated in enclosed photobioreactor facilities ensuring traceability, purity, and year-round production.

Product and service3 records
1AVEPADaily Omega-3 EPA Algal Oil
CategoryOmega-3 EPA algal oil
Description

Premium Omega-3 EPA algal oil produced from the proprietary ALG01 freshwater microalgae strain, cultivated in fully enclosed photobioreactor facilities ensuring complete traceability and contaminant-free production. Marketed to B2B customers in nutraceutical, sports nutrition, personal care and cosmetics, and pharmaceutical markets as a sustainable, vegan, and non-GMO alternative to traditional fish oil.

2ALG01 Grow Agricultural Biostimulant
3ALG01 Origin Algal Biomass
CategoryAlgal biomass ingredients
Description

Versatile algal biomass product derived from proprietary freshwater microalgae strains, sold as a sustainable ingredient source for various applications including nutraceuticals, personal care, functional food, and pharmaceuticals.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
1City of Dessau-Rosslau
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-07-21
Description

Sold 100,000 sq meter property in Flugplatz Dessau industrial area to AlgaeCytes Germany GmbH for commercial plant construction. Lord Mayor Dr. Reck and city council unanimously approved the sale, marking major milestone for company's commercial expansion.

algaecytes.com
2GOLDBECK Nordost GmbH
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Construction and design consultant for the Dessau commercial plant project in Germany.

algaecytes.com
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Design consultant for the Dessau commercial plant project, providing engineering expertise.

4Anhalt University of Applied Sciences
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Located in Saxony-Anhalt region, provides intellectual resources in Algae Biotechnology through its Competence Center Algal Biotechnology. Key research partner supporting company's sustainable operations.

algaecytes.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

R&D and network partnership for algae biotechnology research and development.

6KAUST
Strategic tierCoreTypeStrategic or Co-development Partner
Description

King Abdullah University of Science and Technology - R&D and network partnership for microalgae research.

algaecytes.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

R&D and network partnership for algae cultivation research and development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

R&D and network partnership for microalgae technology development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

R&D and network partnership for algae biotechnology research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

R&D and network partnership for standards and compliance in algae production.

11AlgaeUK
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UK national algae industry association - R&D and network partnership for algae biotechnology sector development.

algaecytes.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

UK government research and innovation body - R&D and network partnership for algae research funding.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

European industry association for algae biomass - R&D and network partnership for sector advancement.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

US-based microalgae technology company producing algae-derived agricultural biostimulants, soil health products, and nutraceutical ingredients via proprietary cultivation platforms. Comparable on microalgae cultivation and biostimulant product overlap with AlgaeCytes’ agricultural line.

TypeBroad incumbent
Description

Global nutrition major with algae and fermentation-derived ingredients capabilities through Biopolis and other units, supplying nutraceutical, food, and personal-care customers. Comparable end-market exposure (nutraceuticals, personal care) and B2B distribution model, with substantially larger scale.

TypeRegional player
Description

Asia-based supplier of specialty oleochemicals and natural ingredients including Omega-3 oils and algae-derived products to nutraceutical and personal care markets. Comparable as an alternative supplier of vegan Omega-3 and natural oils, with stronger APAC distribution than AlgaeCytes.

TypeDirect peer
Description

Iceland-based producer of high-quality astaxanthin and Omega-3 oils from Haematococcus pluvialis and other microalgae using proprietary photobioreactor cultivation. Directly comparable on cultivation technology, ingredient category, and B2B nutraceutical positioning, but with a more mature commercial footprint.

TypeBroad incumbent
Description

Corbion-led AlgaPrime DHA is a whole-algae DHA ingredient produced via fermentation in partnership with Bunge, used primarily in aquaculture feed. Comparable as a producer of microalgae-derived Omega-3, but at much larger scale and focused on feed rather than direct human nutraceutical.

TypeDirect peer
Description

DSM/Evonik joint venture producing algae-based EPA and DHA oils (Veramaris) from natural marine microalgae, targeting pet food, aquaculture, and human nutrition. Closely comparable on technology (algae cultivation, Omega-3 oil) and end markets, with established commercial volumes supplying major aquafeed customers.

7Photonz Corporation
TypeEmerging player
Description

New Zealand-based company focused on producing ultrapure EPA from fermentation of microalgae for pharmaceutical applications. Comparable in strain specialization and high-purity positioning; emerging stage with similar technology pathway to AlgaeCytes’ ALG01 EPA platform.

TypeBroad incumbent
Description

Global nutrition and ingredients major producing life's DHA/EPA from microalgae via its Martek legacy franchise, sold across nutraceutical, infant nutrition, and food applications. Directly comparable as a commercial-scale algae-derived Omega-3 supplier, but with a much broader portfolio and longer customer track record than AlgaeCytes.

TypeBroad incumbent
Description

Global ingredient manufacturer with algae-derived nutritional and specialty ingredients programs (e.g., NUTRALYS, algae-based proteins and lipids). Comparable as a B2B supplier of plant/microbe-derived nutraceutical ingredients, though broader in scope and far larger scale than AlgaeCytes.

TypeEmerging player
Description

Hawaii/Germany-based producer of microalgae-based agricultural biostimulants and crop inputs using proprietary dark fermentation and cultivation technology. Direct overlap with AlgaeCytes’ ALG01 Grow biostimulant line and similar sustainability positioning, but earlier commercial stage.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AlgaeCytes

Microalgae-derived ingredientsalgaecytes.com

AlgaeCytes is a UK biotechnology company that uses enclosed photobioreactors and proprietary freshwater microalgae strains to produce vegan Omega-3 EPA oils, agricultural biostimulants, and algal biomass ingredients for B2B customers in nutraceuticals, sports nutrition, personal care, pharmaceutical, and agricultural markets.

What AlgaeCytes does

AlgaeCytes is a UK-based biotechnology company founded in 2010 that cultivates freshwater microalgae in enclosed photobioreactor systems to produce sustainable, vegan-friendly ingredients for B2B customers. The company operates from its headquarters at Discovery Park in Sandwich, Kent, with a wholly owned German subsidiary (AlgaeCytes Germany GmbH) running a 100,000 square meter commercial-scale plant in Dessau-Roßlau, Saxony-Anhalt, that commenced operations in 2024. AlgaeCytes' core technology consists of rows of enclosed glass tubing with LED-stimulated photosynthesis, controlled temperature, and regulated nutrient supply, enabling year-round 24/7 production independent of weather and protection against heavy metals, PCBs, and pesticides. Its product portfolio centers on the proprietary ALG01 microalgae strain and includes AVEPADaily (Omega-3 EPA algal oil for nutraceuticals and dietary supplements), ALG01 Grow (an agricultural biostimulant for organic crop cultivation), and ALG01 Origin (versatile algal biomass for personal care, functional food, and pharmaceutical applications).

The company sells ingredients under a one-time/license B2B model to nutraceutical, sports nutrition, personal care and cosmetics, pharmaceutical, and agricultural customers globally, going to market primarily through enterprise field sales and industry event participation (SupplySide West 2023/2024, GOED Exchange 2024). Pricing is not publicly disclosed, and no anchor customer logos or revenue figures are reported. Since 2013, Deepbridge Capital LLP has been the principal financial backer via the Deepbridge Technology Growth EIS fund, with additional support from Kent County Council and approximately $12.5M from the German Federal Ministry for Economic Affairs and Energy (BMWi) in 2022 toward the Dessau build. AlgaeCytes is transitioning from pilot-scale operations (Kent, since November 2017) to commercial-scale production (Dessau, since 2024) and maintains R&D partnerships with KAUST, Fraunhofer Institute, University of Manchester, University of Nottingham, and Anhalt University of Applied Sciences.

AlgaeCytes firmographics

Firmographics
Name
AlgaeCytes
Legal name
AlgaeCytes Limited
Website
https://algaecytes.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
AlgaeCytes is a UK biotechnology company that uses enclosed photobioreactors and proprietary freshwater microalgae strains to produce vegan Omega-3 EPA oils, agricultural biostimulants, and algal biomass ingredients for B2B customers in nutraceuticals, sports nutrition, personal care, pharmaceutical, and agricultural markets.
Ownership category
akta.pro rank

AlgaeCytes industry classification

Industry
Product category
Microalgae-derived ingredients
NAICS
Aquaculture (1125), Other Aquaculture (112519), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)
SIC
Medicinal Chemicals & Botanical Products (2833), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYAFAEAAAE
Seaweed & Algae Aquaculture (incl. microalgae)
Agriculture & Food Production/Animal Production & Aquaculture/Aquaculture (Fish & Shellfish Farming)
SECONDARYAFABAEAK
Biostimulants & Plant Health Biologicals (Microbial/Non-microbial)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYAFAJAHAF
Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)

Keywords

  • Microalgae cultivation
  • Omega-3 EPA oil
  • Algal biostimulants
  • Photobioreactor systems
  • Algae-derived ingredients

Where AlgaeCytes is headquartered

Location

Headquarters

HQ city
Sandwich
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

AlgaeCytes business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Infrastructure, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Omega-3 EPA Algal Oil Sales: AlgaeCytes produces and sells AVEPADaily, a premium Omega-3 EPA algal oil to B2B customers in dietary supplements, sports nutrition, personal care & cosmetics, and pharmaceutical markets. The product is positioned as a natural, vegan-friendly, non-GMO alternative to fish oil.
  2. Agricultural Biostimulant Sales: ALG01 Grow, a sustainable algal-based agricultural crop biostimulant sold to the agricultural sector for organic crop cultivation, promoting healthier plant growth and soil health.
  3. Algal Biomass Ingredients: Sale of ALG01 Origin versatile algal biomass to various industries including nutraceuticals, personal care, functional food, and pharmaceuticals.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

AlgaeCytes product offering

Product offering

Core offering

AlgaeCytes cultivates microalgae in enclosed photobioreactor systems to produce and sell B2B ingredients including AVEPADaily Omega-3 EPA algal oil, ALG01 Grow agricultural biostimulant, and ALG01 Origin versatile algal biomass. The company supplies these all-natural, vegan-friendly, non-GMO ingredients to dietary supplement, sports nutrition, personal care & cosmetics, pharmaceutical, and agricultural customers globally. Production occurs in fully enclosed facilities using proprietary freshwater microalgae strains and patented processes that enable year-round, contaminant-free manufacturing.

Product overview

AlgaeCytes is a biotechnology company that cultivates microalgae to produce high-value natural ingredients for B2B customers. The company offers two core product lines: (1) AVEPADaily, a premium Omega-3 EPA algal oil derived from the proprietary ALG01 strain - the first vegan and non-GMO alternative to traditional fish oils; and (2) ALG01 Grow, an agricultural biostimulant made from nutrient-rich algal biomass for organic crop cultivation. The company also produces ALG01 Origin, a versatile algal biomass ingredient. All products are cultivated in enclosed photobioreactor facilities ensuring traceability, purity, and year-round production.

Differentiator

Problem solved

Functional benefit

Brands

  • AVEPADaily: Premium range of Omega-3 EPA algal oil - a natural, vegan-friendly, and non-GMO source of Omega-3 EPAs for nutraceuticals and wellness products.
  • ALG01 Grow
  • ALG01 Origin

Products and services

  • AVEPADaily Omega-3 EPA Algal Oil Premium Omega-3 EPA algal oil produced from the proprietary ALG01 freshwater microalgae strain, cultivated in fully enclosed photobioreactor facilities ensuring complete traceability and contaminant-free production. Marketed to B2B customers in nutraceutical, sports nutrition, personal care and cosmetics, and pharmaceutical markets as a sustainable, vegan, and non-GMO alternative to traditional fish oil.
  • ALG01 Grow Agricultural Biostimulant
  • ALG01 Origin Algal Biomass Versatile algal biomass product derived from proprietary freshwater microalgae strains, sold as a sustainable ingredient source for various applications including nutraceuticals, personal care, functional food, and pharmaceuticals.

Quantifiable outcome

  • Contaminant-free: No heavy metals, PCBs, pesticides, or environmental pollutants in products
  • +3 more outcomes

Companies that use AlgaeCytes

Customer profile

Segments5 records

Ideal customer profiles4 records

AlgaeCytes technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

AlgaeCytes partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • City of Dessau-RosslaucoreStrategic or Co-development Partner · 21 July 2021Sold 100,000 sq meter property in Flugplatz Dessau industrial area to AlgaeCytes Germany GmbH for commercial plant construction. Lord Mayor Dr. Reck and city council unanimously approved the sale, marking major milestone for company's commercial expansion.
  • GOLDBECK Nordost GmbHminorImplementation/ SI/ Consulting PartnerConstruction and design consultant for the Dessau commercial plant project in Germany.
  • Fichtner Consulting Engineers Ltd.minorImplementation/ SI/ Consulting PartnerDesign consultant for the Dessau commercial plant project, providing engineering expertise.
  • Anhalt University of Applied SciencescoreStrategic or Co-development PartnerLocated in Saxony-Anhalt region, provides intellectual resources in Algae Biotechnology through its Competence Center Algal Biotechnology. Key research partner supporting company's sustainable operations.
  • Hochschule Anhalt University of Applied SciencescoreStrategic or Co-development PartnerR&D and network partnership for algae biotechnology research and development.
  • KAUSTcoreStrategic or Co-development PartnerKing Abdullah University of Science and Technology - R&D and network partnership for microalgae research.
  • University of ManchestercoreStrategic or Co-development PartnerR&D and network partnership for algae cultivation research and development.
  • Fraunhofer InstitutecoreStrategic or Co-development PartnerR&D and network partnership for microalgae technology development.
  • University of NottinghamcoreStrategic or Co-development PartnerR&D and network partnership for algae biotechnology research.
  • BSI GroupminorStrategic or Co-development PartnerR&D and network partnership for standards and compliance in algae production.
  • AlgaeUKcoreStrategic or Co-development PartnerUK national algae industry association - R&D and network partnership for algae biotechnology sector development.
  • UK Research and Innovation (UKRI)minorStrategic or Co-development PartnerUK government research and innovation body - R&D and network partnership for algae research funding.
  • European Algae Biomass AssociationcoreStrategic or Co-development PartnerEuropean industry association for algae biomass - R&D and network partnership for sector advancement.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

AlgaeCytes competitors and assessment

Company assessment

Emerging players

  • Heliae Development: US-based microalgae technology company producing algae-derived agricultural biostimulants, soil health products, and nutraceutical ingredients via proprietary cultivation platforms. Comparable on microalgae cultivation and biostimulant product overlap with AlgaeCytes’ agricultural line.
  • Photonz Corporation: New Zealand-based company focused on producing ultrapure EPA from fermentation of microalgae for pharmaceutical applications. Comparable in strain specialization and high-purity positioning; emerging stage with similar technology pathway to AlgaeCytes’ ALG01 EPA platform.
  • Kuehnle AgroSystem: Hawaii/Germany-based producer of microalgae-based agricultural biostimulants and crop inputs using proprietary dark fermentation and cultivation technology. Direct overlap with AlgaeCytes’ ALG01 Grow biostimulant line and similar sustainability positioning, but earlier commercial stage.

Broad incumbents

  • ADM (Biopolis / Dextra): Global nutrition major with algae and fermentation-derived ingredients capabilities through Biopolis and other units, supplying nutraceutical, food, and personal-care customers. Comparable end-market exposure (nutraceuticals, personal care) and B2B distribution model, with substantially larger scale.
  • Corbion (AlgaPrime): Corbion-led AlgaPrime DHA is a whole-algae DHA ingredient produced via fermentation in partnership with Bunge, used primarily in aquaculture feed. Comparable as a producer of microalgae-derived Omega-3, but at much larger scale and focused on feed rather than direct human nutraceutical.
  • DSM-firmenich (Martek life’s Omega-3): Global nutrition and ingredients major producing life's DHA/EPA from microalgae via its Martek legacy franchise, sold across nutraceutical, infant nutrition, and food applications. Directly comparable as a commercial-scale algae-derived Omega-3 supplier, but with a much broader portfolio and longer customer track record than AlgaeCytes.
  • Roquette (Algae Ingredients): Global ingredient manufacturer with algae-derived nutritional and specialty ingredients programs (e.g., NUTRALYS, algae-based proteins and lipids). Comparable as a B2B supplier of plant/microbe-derived nutraceutical ingredients, though broader in scope and far larger scale than AlgaeCytes.

Regional players

  • Ecogreen Oleochemicals: Asia-based supplier of specialty oleochemicals and natural ingredients including Omega-3 oils and algae-derived products to nutraceutical and personal care markets. Comparable as an alternative supplier of vegan Omega-3 and natural oils, with stronger APAC distribution than AlgaeCytes.

Direct peers

  • Algalif: Iceland-based producer of high-quality astaxanthin and Omega-3 oils from Haematococcus pluvialis and other microalgae using proprietary photobioreactor cultivation. Directly comparable on cultivation technology, ingredient category, and B2B nutraceutical positioning, but with a more mature commercial footprint.
  • Veramaris: DSM/Evonik joint venture producing algae-based EPA and DHA oils (Veramaris) from natural marine microalgae, targeting pet food, aquaculture, and human nutrition. Closely comparable on technology (algae cultivation, Omega-3 oil) and end markets, with established commercial volumes supplying major aquafeed customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

AlgaeCytes social profiles

Digital presence

AlgaeCytes financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AlgaeCytes leadership team

Management profile

Number of profiles

Profiles1 record

AlgaeCytes subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

AlgaeCytes funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AlgaeCytes M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AlgaeCytes

What does AlgaeCytes do?

AlgaeCytes cultivates microalgae in enclosed photobioreactor systems to produce and sell B2B ingredients including AVEPADaily Omega-3 EPA algal oil, ALG01 Grow agricultural biostimulant, and ALG01 Origin versatile algal biomass. The company supplies these all-natural, vegan-friendly, non-GMO ingredients to dietary supplement, sports nutrition, personal care & cosmetics, pharmaceutical, and agricultural customers globally. Production occurs in fully enclosed facilities using proprietary freshwater microalgae strains and patented processes that enable year-round, contaminant-free manufacturing.

Is AlgaeCytes a public or private company?

AlgaeCytes is a private company. It is classified as venture growth investor backed and is currently operating.

When was AlgaeCytes founded?

AlgaeCytes was founded in 2010. It employs 11 to 50 people.

Where is AlgaeCytes based?

AlgaeCytes is headquartered in Sandwich, United Kingdom, in the Europe region.

How does AlgaeCytes make money?

Three revenue lines are on record. Omega-3 EPA Algal Oil Sales are the primary driver. The others are agricultural Biostimulant Sales and algal Biomass Ingredients.

Who are AlgaeCytes's main competitors?

Emerging players on record are Heliae Development, Photonz Corporation and Kuehnle AgroSystem. Broad incumbents are ADM (Biopolis / Dextra), Corbion (AlgaPrime), DSM-firmenich (Martek life’s Omega-3) and Roquette (Algae Ingredients). Ecogreen Oleochemicals is listed as a regional player. Direct peers are Algalif and Veramaris.

Does AlgaeCytes have an API?

No public API is recorded for AlgaeCytes.

What industry is AlgaeCytes in?

AlgaeCytes's product category is Microalgae-derived ingredients. Its primary akta.pro industry code is AFAEAAAE, Seaweed & Algae Aquaculture (incl. microalgae), with a secondary code of AFABAEAK, Biostimulants & Plant Health Biologicals (Microbial/Non-microbial). Its NAICS code is 1125 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
London Tech NewsSustainable tech company AlgaeCytes secures €16m of funding - London Tech NewsAlgaeCytes secured €16m in funding from IBG and the German Federal Ministry, with €11m from the GRW programme. The €60m project will build a bioreactor in Dessau, Saxony-Anhalt, for vegan Omega-3 oil production, expected operational in early 2023.Kent OnlineAlgaeCytes to expand commercial production of health ingredients from algae with new facility at Discovery Park in SandwichAlgaeCytes opened a new facility in Discovery Park, Sandwich, to begin commercial production of algae-derived health ingredients. The company plans to add 50,000 sq ft of lab space and expand office capacity, aiming to increase production to meet demand. The expansion is part of a multi-million pound investment by Discovery Park.PR NewswireAfrica Algae Omega-3 Ingredient Market (2017-2022): Key Players are DSM Nutritional Products, Algaecytes, Bioprocess Algae, Terravia & Qualitas HealthResearch and Markets announced on July 31, 2017 the addition of a report on the Africa algae omega-3 ingredient market, covering growth, trends and forecasts through 2022. The report projects a 9.9% CAGR, with South Africa leading due to health awareness and infant formula demand. High production and processing costs, plus weak regulatory structures, are cited as growth constraints.PR NewswireAsia-Pacific Algae Omega-3 Ingredient Market (2017-2022): Driven by High Consumption of Infant Formula Products in ChinaResearch and Markets has published a market report on the Asia-Pacific algae omega-3 ingredient market, projecting it to grow at a CAGR of 13.2% during 2017-2022, making it the fastest-growing region globally for this ingredient. The primary growth driver is the high consumption of infant formula products in China, where DHA fortification in infant formula is legally mandated. Key challenges include high production costs and expensive downstream processing, while market players include DSM, Bioprocess Algae, Algaecytes, Terravia, and Qualitas Health.